Scientific Program
September 6 (9.30 – 18.15)

Anne de Brugerolle - CEO – SkinEthic
Overview


1 - REGULATORY SESSION:

9.30 – 10.00:
Claudius GRIESINGER (PhD) - European Commission
ECVAM validations – past successes and future challenges

10.00 – 10.30:
Horst Spielmann - Former Head of Department BfR
Overview of the alternative methods available at world-wide level

10.30 – 11.00:
Isabelle Fabre – AFSSAPS - Head of Cell and Molecular Biology Unit
Position of alternative methods to animal testing
in safety controls of health products for human use.
Afssaps initiatives

11.00 – 11.15:Coffee break

11.15 – 12.00:
Rachida SEMAIL & Mark BOELENS – Keller & Heckman
How to deal with the new regulatory framework
REACh program – EU Cosmetic Directive

12.00 – 12.30:
Pauline Mac NAMEE - COLIPA Task Force
The Colipa Eye Irritation Programme: Recent Developments
in Method Development/Optimisation of
Existing In Vitro Methods: Focus on SkinEthic Human Corneal Epithelial Model


12.30 - 14.00:lunch



2 - INNOVATIVE TESTING SESSION:

14.00 – 14.30:
Attila GACSER – Albert Einstein College of Medecine
Reconstituted Human Tissues facilitate the analysis of
Candida parapsilosis virulence factors and host-pathogen interactions

14.30 – 15.00:
Carine Tornier – SkinEthic
New In Vitro Patch Test using non invasive end points

15.00 – 15.30:
Ulrich LERMANN – University of Wuerzburg
Analysis of virulence factors of human fungal pathogen Candida albicans

15:30 – 16.00:
G. Lerebour – L’Oréal R&D
Bacterial Adhesion Test

16.00 - 16.15:lunch


16.15 – 16.45:Julian NAGLIK – King’s College London Dental Institute
Host-fungal interactions: role of innate immunity

16.45 – 17.15:Günther WEINDL - Department of Dermatology,
Eberhard Karls University Tübingen
Studying innate immune responses during Candida infections using in vitro human tissue models

17.15 – 17.45:Michelle Rathman – L’Oréal R&D
Evaluation of the Skin Coloration

17.45 – 18.15:Joanna L. Rowland – GLAXO SMITHKLINE
Development & Validation of an In Vitro Oral Soft Tissue Model
for Assessing Potential Toxicity of Actives & Excipients



September 7 (9.00 – 14.00)


3 - NEW MODELS SESSION:

9.00 – 9.30:Daniel ASSELINEAU & Nathalie BOYERA – L’Oréal R&D
RealSkin: a promising model of
full thickness reconstructed human skin

9.30 – 10.00:Gladys OUEDRAOGO-ARRAS – L’Oréal R&D
Genotoxicity – A new and promising use of in vitro models

10.00 – 10.45:Miki Blumenberg - Dept of Dermatology New York University School of Medicine
Skin Disease Model: Psoriasis


10.45 – 11.15:Coffee break

11.15 – 11.45:F. Sahuc – R&D Manager SkinEthic
Nasal Epithelium – Up to date information and perspectives

11.45 – 12.15:Pr. Beuerman – Singapore Eye Research Institute
Developing In Vitro Models for Ocular Toxicology

12.15 - 14.00:lunch